“…More commonly found in the peritoneal cavity, these neoplasms, referred to as well-differentiated papillary mesothelial tumor (WDPMT) or well-differentiated papillary mesothelioma (WDPM), are rarely seen in the testis. Initially described in 1957 by Bárbera et al, a few dozen such tumors have to date been reported in the literature, one of the most important series reported being the work of Brimo et al [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16] Typically, these neoplasms show no architectural complexity, whereas borderline tumors with more complex architectures or areas of uncertain invasion are reported and pose a diagnostic challenge as there is an ongoing debate about whether to classify these as benign or of uncertain malignant potential, with consequences for further patient management and patient perception of their illness. 4,5,8,15 In recent years, new molecular analytical tools, including BAP1 immunohistochemistry, have emerged, probably aiding in the diagnostic classification.…”